Effects of alpha lipoic acid supplementation on serum levels of IL-8 and TNF-α in patient with ESRD undergoing hemodialysis

[1]  S. Yildirim,et al.  Evaluation of the serum cystatin C values in prediction of indications for hemodialysis in patients with chronic renal failure , 2013, International Urology and Nephrology.

[2]  R. Mahdavi,et al.  Effects of alpha-lipoic acid supplementation on inflammation, oxidative stress, and serum lipid profile levels in patients with end-stage renal disease on hemodialysis. , 2012, Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation.

[3]  A. Pakpour,et al.  Validity and reliability of short form-12 questionnaire in Iranian hemodialysis patients. , 2011, Iranian journal of kidney diseases.

[4]  T. Ikizler,et al.  Effects of combination tocopherols and alpha lipoic acid therapy on oxidative stress and inflammatory biomarkers in chronic kidney disease. , 2011, Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation.

[5]  D. Spandidos,et al.  Interleukin 8 and cardiovascular disease. , 2009, Cardiovascular research.

[6]  C. Lam.  2. Inflammation, Cytokines and Chemokines in Chronic Kidney Disease , 2009, EJIFCC.

[7]  S. Delemasure,et al.  Un dithiol endogène aux propriétés antioxydantes : l’acide alpha-lipoïque, utilisation potentielle dans les pathologies cardiovasculaires , 2008 .

[8]  G. Biolo,et al.  Insulin action on glucose and protein metabolism during L-carnitine supplementation in maintenance haemodialysis patients. , 2007, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[9]  A. Prigent,et al.  Monitoring renal function and limitations of renal function tests. , 2008, Seminars in nuclear medicine.

[10]  C. Vergely,et al.  [An endogenous dithiol with antioxidant properties: alpha-lipoic acid, potential uses in cardiovascular diseases]. , 2008, Annales de cardiologie et d'angeiologie.

[11]  Eun Kyoung Lee,et al.  Effects of α-Lipoic Acid on the Plasma Levels of Asymmetric Dimethylarginine in Diabetic End-Stage Renal Disease Patients on Hemodialysis: A Pilot Study , 2007, American Journal of Nephrology.

[12]  M. Ilić,et al.  Metabolic syndrome in HD patients: association with body composition, nutritional status, inflammation and serum iron. , 2007, Internal medicine.

[13]  S. Moe,et al.  Review of the effects of omega-3 supplementation in dialysis patients. , 2006, Clinical journal of the American Society of Nephrology : CJASN.

[14]  L. Ghiadoni,et al.  Interleukin-8 Is a Powerful Prognostic Predictor of All-Cause and Cardiovascular Mortality in Dialytic Patients , 2005, Nephron Clinical Practice.

[15]  M. Zaniew,et al.  Beneficial in vitro effect of N-acetyl-cysteine on oxidative stress and apoptosis , 2005, Pediatric Nephrology.

[16]  M. Bahçeci,et al.  The comparison of insulin sensitivity in non-diabetic hemodialysis patients treated with and without recombinant human erythropoietin. , 2004, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

[17]  M. Olszewska.  [The effect of hemodialysis on some parameters of the antioxidant system in the blood of patients with chronic renal failure]. , 2004, Annales Academiae Medicae Stetinensis.

[18]  R. Wolfe,et al.  Markers of inflammation, proteolysis, and apoptosis in ESRD. , 2003, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[19]  P. Jones,et al.  Alpha-lipoic acid and cardiovascular disease. , 2003, The Journal of nutrition.

[20]  P. O'Brien,et al.  The Sensory Symptoms of Diabetic Polyneuropathy Are Improved With α-Lipoic Acid , 2003 .

[21]  P. O'Brien,et al.  The sensory symptoms of diabetic polyneuropathy are improved with alpha-lipoic acid: the SYDNEY trial. , 2003, Diabetes care.

[22]  P. Stenvinkel,et al.  Review Articles: Inflammation in End‐stage Renal Disease: Sources, Consequences, and Therapy , 2002, Seminars in dialysis.

[23]  R. Somwar,et al.  The antihyperglycemic drug alpha-lipoic acid stimulates glucose uptake via both GLUT4 translocation and GLUT4 activation: potential role of p38 mitogen-activated protein kinase in GLUT4 activation. , 2001, Diabetes.

[24]  G. Biessels,et al.  Glutathione and α‐lipoate in diabetic rats: nerve function, blood flow and oxidative state , 2001, European journal of clinical investigation.

[25]  S. Jain,et al.  Lipoic acid decreases lipid peroxidation and protein glycosylation and increases (Na(+) + K(+))- and Ca(++)-ATPase activities in high glucose-treated human erythrocytes. , 2000, Free radical biology & medicine.

[26]  D. Greene,et al.  Effects of DL-alpha-lipoic acid on peripheral nerve conduction, blood flow, energy metabolism, and oxidative stress in experimental diabetic neuropathy. , 2000, Diabetes.

[27]  I. Goldfine,et al.  Alpha-lipoic acid: a multifunctional antioxidant that improves insulin sensitivity in patients with type 2 diabetes. , 2000, Diabetes technology & therapeutics.

[28]  H. Tritschler,et al.  Alpha-lipoic acid: effect on glucose uptake, sorbitol pathway, and energy metabolism in experimental diabetic neuropathy. , 1999, Diabetes.

[29]  M. Hanefeld,et al.  Treatment of symptomatic diabetic polyneuropathy with the antioxidant alpha-lipoic acid: a 7-month multicenter randomized controlled trial (ALADIN III Study). ALADIN III Study Group. Alpha-Lipoic Acid in Diabetic Neuropathy. , 1999, Diabetes care.

[30]  F. Gries,et al.  Effects of treatment with the antioxidant alpha-lipoic acid on cardiac autonomic neuropathy in NIDDM patients. A 4-month randomized controlled multicenter trial (DEKAN Study). Deutsche Kardiale Autonome Neuropathie. , 1997, Diabetes care.

[31]  P. Jungers,et al.  Glutathione antioxidant system as a marker of oxidative stress in chronic renal failure. , 1996, Free radical biology & medicine.

[32]  A. Diplock,et al.  Antioxidants and disease prevention. , 1994, Molecular aspects of medicine.